Cargando…

Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda

BACKGROUND: Human papillomavirus (HPV) vaccination is an effective public health measure for the prevention of cancer of the cervix. We aimed to assess HPV vaccine coverage and associated factors in Gulu, Uganda. METHODS: In October 2021, we conducted a cross-sectional study among girls aged 9 to 13...

Descripción completa

Detalles Bibliográficos
Autores principales: Odongo Ojok, Isaac, Ogwal, John Baptist, Wwesige, Brian, Bongomin, Felix, Akello, Franceska
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083017/
https://www.ncbi.nlm.nih.gov/pubmed/37041756
http://dx.doi.org/10.2147/AHMT.S397734
_version_ 1785021421105184768
author Odongo Ojok, Isaac
Ogwal, John Baptist
Wwesige, Brian
Bongomin, Felix
Akello, Franceska
author_facet Odongo Ojok, Isaac
Ogwal, John Baptist
Wwesige, Brian
Bongomin, Felix
Akello, Franceska
author_sort Odongo Ojok, Isaac
collection PubMed
description BACKGROUND: Human papillomavirus (HPV) vaccination is an effective public health measure for the prevention of cancer of the cervix. We aimed to assess HPV vaccine coverage and associated factors in Gulu, Uganda. METHODS: In October 2021, we conducted a cross-sectional study among girls aged 9 to 13 years residing in Pece-Laroo Division, Gulu City, Uganda. HPV vaccine coverage was defined as receipt of at least a dose of the HPV vaccine. RESULTS: A total of 197 girls, with a mean age of 11±1.4 years, were enrolled. Most participants were of the Acholi tribe (89.3%, n=176), catholic (58.4%, n=115), and in primary 5 level of education (36%, n=71). Overall, 68(35%) participants had received the HPV vaccine. Factors associated with HPV vaccine utilization were, good knowledge of the HPV vaccine (adjusted odds ratio (aOR) =0.233, 95% confidence interval (95CI): 0.037–0.640, p=0.101), methods of HPV prevention (OR=0.320, 95CI: 0.112–0.914, p = 0.033), good knowledge of the importance of HPV vaccination (OR=0.458, 95% CI: 0.334–0.960, p=0.021), knowledge on frequency of HPV vaccination (OR=0.423, 95CI:0.173–0.733, p=0.059), and good mobilization (OR=0.443, 95% CI: 0.023–0.923, p=0.012). CONCLUSION: In this community-based study, only one third of eligible girls received the HPV vaccine. Public health interventions are recommended exponentially to enhance the utilization of the HPV vaccine in this community.
format Online
Article
Text
id pubmed-10083017
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-100830172023-04-10 Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda Odongo Ojok, Isaac Ogwal, John Baptist Wwesige, Brian Bongomin, Felix Akello, Franceska Adolesc Health Med Ther Original Research BACKGROUND: Human papillomavirus (HPV) vaccination is an effective public health measure for the prevention of cancer of the cervix. We aimed to assess HPV vaccine coverage and associated factors in Gulu, Uganda. METHODS: In October 2021, we conducted a cross-sectional study among girls aged 9 to 13 years residing in Pece-Laroo Division, Gulu City, Uganda. HPV vaccine coverage was defined as receipt of at least a dose of the HPV vaccine. RESULTS: A total of 197 girls, with a mean age of 11±1.4 years, were enrolled. Most participants were of the Acholi tribe (89.3%, n=176), catholic (58.4%, n=115), and in primary 5 level of education (36%, n=71). Overall, 68(35%) participants had received the HPV vaccine. Factors associated with HPV vaccine utilization were, good knowledge of the HPV vaccine (adjusted odds ratio (aOR) =0.233, 95% confidence interval (95CI): 0.037–0.640, p=0.101), methods of HPV prevention (OR=0.320, 95CI: 0.112–0.914, p = 0.033), good knowledge of the importance of HPV vaccination (OR=0.458, 95% CI: 0.334–0.960, p=0.021), knowledge on frequency of HPV vaccination (OR=0.423, 95CI:0.173–0.733, p=0.059), and good mobilization (OR=0.443, 95% CI: 0.023–0.923, p=0.012). CONCLUSION: In this community-based study, only one third of eligible girls received the HPV vaccine. Public health interventions are recommended exponentially to enhance the utilization of the HPV vaccine in this community. Dove 2023-04-05 /pmc/articles/PMC10083017/ /pubmed/37041756 http://dx.doi.org/10.2147/AHMT.S397734 Text en © 2023 Odongo Ojok et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Odongo Ojok, Isaac
Ogwal, John Baptist
Wwesige, Brian
Bongomin, Felix
Akello, Franceska
Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda
title Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda
title_full Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda
title_fullStr Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda
title_full_unstemmed Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda
title_short Factors Associated with the Human Papillomavirus Vaccine Coverage in Gulu District, Uganda
title_sort factors associated with the human papillomavirus vaccine coverage in gulu district, uganda
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083017/
https://www.ncbi.nlm.nih.gov/pubmed/37041756
http://dx.doi.org/10.2147/AHMT.S397734
work_keys_str_mv AT odongoojokisaac factorsassociatedwiththehumanpapillomavirusvaccinecoverageinguludistrictuganda
AT ogwaljohnbaptist factorsassociatedwiththehumanpapillomavirusvaccinecoverageinguludistrictuganda
AT wwesigebrian factorsassociatedwiththehumanpapillomavirusvaccinecoverageinguludistrictuganda
AT bongominfelix factorsassociatedwiththehumanpapillomavirusvaccinecoverageinguludistrictuganda
AT akellofranceska factorsassociatedwiththehumanpapillomavirusvaccinecoverageinguludistrictuganda